Rainer Kramer
Signal active
MD & Chief Business Officer
Contact Information
Social
Primary Organization
immatics biotechnologies
Founded
2000
Employees
101-250
Industry
Biotechnology, Medical, Therapeutics
Bio
Rainer Kramer joined immatics as Chief Business Officer in April 2012 from Signature Diagnostics AG where he was Chief Business Officer as well. Rainer is primarily responsible for immatics’ licensing & partnering activities.
During his career he has delivered numerous strategic partnerships and license deals encompassing tech-nology platform and product deals as well as equity transactions with an aggregate value of several hundred million Euros whilst working in business development functions at Jerini AG, MorphoSys AG, Martinsried, and Amgen Inc. During the sale of Jerini to Shire in 2008 Rainer was a member of Jerini’s M&A committee and Shire’s appointed principal for sale of JPT GmbH in 2009.
Rainer holds a Diploma in Molecular Biology from University of Regensburg and a PhD from Max-Planck-Institute for Neurobiology.
Location
Tübingen, Baden-Wurttemberg, Germany, Europe
Jobs history
0
N/A
Educations
2
The Max Planck Institute
Neurobiology
University of Regensburg
Molecular Biology
Profile Resume
Rainer Kramer is the MD & Chief Business Officer at immatics biotechnologies, based in Europe. With a background in Biotechnology, Rainer Kramer has a rich history of leadership and innovation.Rainer Kramer studied Ph.D. Neurobiology at The Max Planck Institute. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.